BROGI, SIMONE Statistiche
BROGI, SIMONE
DIPARTIMENTO DI FARMACIA
A novel potent class I HDAC inhibitor reverses the STAT4/p66Shc apoptotic defect in B cells from chronic lymphocytic leukemia patients
2024-01-01 Rossi, S.; Tatangelo, V.; Dichiara, M.; Butini, S.; Gemma, S.; Brogi, S.; Pasquini, S.; Cappello, M.; Vincenzi, F.; Varani, K.; Lopresti, L.; Malchiodi, M.; Carrara, C.; Gozzetti, A.; Bocchia, M.; Marotta, G.; Patrussi, L.; Carullo, G.; Baldari, C. T.; Campiani, G.
A virtual insight into mushroom secondary metabolites: 3D-QSAR, docking, pharmacophore-based analysis and molecular modeling to analyze their anti-breast cancer potential
2024-01-01 Shafiq, N.; Shakoor, B.; Yaqoob, N.; Parveen, S.; Brogi, S.; Mohammad Salamatullah, A.; Rashid, M.; Bourhia, M.
Development of Potent and Selective Monoacylglycerol Lipase Inhibitors. SARs, Structural Analysis, and Biological Characterization
2024-01-01 Butini, S.; Grether, U.; Jung, K. -M.; Ligresti, A.; Allara, M.; Postmus, A. G. J.; Maramai, S.; Brogi, S.; Papa, A.; Carullo, G.; Sykes, D.; Veprintsev, D.; Federico, S.; Grillo, A.; Di Guglielmo, B.; Ramunno, A.; Stevens, A. F.; Heer, D.; Lamponi, S.; Gemma, S.; Benz, J.; Di Marzo, V.; van der Stelt, M.; Piomelli, D.; Campiani, G.
Exploring Citrus sinensis Phytochemicals as Potential Inhibitors for Breast Cancer Genes BRCA1 and BRCA2 Using Pharmacophore Modeling, Molecular Docking, MD Simulations, and DFT Analysis
2024-01-01 Zia, M.; Parveen, S.; Shafiq, N.; Rashid, M.; Farooq, A.; Dauelbait, M.; Shahab, M.; Salamatullah, A. M.; Brogi, S.; Bourhia, M.
Lithocholic acid derivatives as potent modulators of the nuclear receptor RORγt
2024-01-01 Abdel-Rahman, S. A.; Brogi, S.; Gabr, M. T.
Multi-Technique Approach to Identify Potent Antimicrobial Agents from Calotropis procera: Insight into Pharmacophore Modeling, Molecular docking, MD simulation, and DFT Approaches
2024-01-01 Rashid, M.; Sajjad, N.; Shafiq, N.; Parveen, S.; Khan, R. A.; Farooq, A.; Shaha, M.; Dawoud, T. M.; Brogi, S.; Bourhia, M.
Natural products as non-covalent and covalent modulators of the KEAP1/NRF2 pathway exerting antioxidant effects
2024-01-01 Culletta, G.; Buttari, B.; Arese, M.; Brogi, S.; Almerico, A. M.; Saso, L.; Tutone, M.
Characterization of stenocephol from Seriphidium stenocephalum as potent HepG2 cell growth and glycogen phosphorylase inhibitor
2023-01-01 Shafiq, N.; Arshad, U.; Brogi, S.; Rashid, M.; Rafiq, N.; Parveen, S.
Computation to Fight SARS-CoV-2 (COVID-19)
2023-01-01 Brogi, S.; Calderone, V.
Design, synthesis, and biological investigation of oxadiazolyl, thiadiazolyl, and pyrimidinyl linked antipyrine derivatives as potential non-acidic anti-inflammatory agents
2023-01-01 Al-Sanea, M. M.; Hamdi, A.; Brogi, S.; S Tawfik, S.; Othman, D. I. A.; Elshal, M.; Ur Rahman, H.; Parambi, D. G. T.; M Elbargisy, R.; Selim, S.; Mostafa, E. M.; Mohamed, A. A. B.
Development of Quinazolinone Derivatives as Modulators of Virulence Factors of Pseudomonas aeruginosa Cystic Fibrosis Strains
2023-01-01 Carullo, G.; Di Bonaventura, G.; Rossi, S.; Lupetti, V.; Tudino, V.; Brogi, S.; Butini, S.; Campiani, G.; Gemma, S.; Pompilio, A.
Developmental landscape of computational techniques to explore the potential phytochemicals from Punica granatum peels for their antioxidant activity in Alzheimer’s disease
2023-01-01 Parveen, S.; Batool, A.; Shafiq, N.; Rashid, M.; Sultan, A.; Wondmie, G. F.; Bin Jardan, Y. A.; Brogi, S.; Bourhia, M.
Discovery of novel direct small-molecule inhibitors targeting HIF-2α using structure-based virtual screening, molecular dynamics simulation, and MM-GBSA calculations
2023-01-01 Yazdani, B.; Sirous, H.; Enguita, F. J.; Brogi, S.; Wing, P. A. C.; Fassihi, A.
Disruption of Irisin Dimerization by FDA-Approved Drugs: A Computational Repurposing Approach for the Potential Treatment of Lipodystrophy Syndromes
2023-01-01 Flori, L.; Brogi, S.; Sirous, H.; Calderone, V.
Editorial: Advances in green synthesis for drug discovery
2023-01-01 Allais, F.; Brogi, S.; Castro, G. R.; Vidali, V. P.
Exploration of phenolic acid derivatives as inhibitors of SARS-CoV-2 main protease and receptor binding domain: potential candidates for anti-SARS-CoV-2 therapy
2023-01-01 Shafiq, N.; Mehroze, A.; Sarwar, W.; Arshad, U.; Parveen, S.; Rashid, M.; Farooq, A.; Rafiq, N.; Wondmie, G. F.; Bin Jardan, Y. A.; Brogi, S.; Bourhia, M.
Identification of Sesamin from Sesamum indicum as a Potent Antifungal Agent Using an Integrated in Silico and Biological Screening Platform
2023-01-01 Wadhwa, K.; Kaur, H.; Kapoor, N.; Brogi, S.
In Silico Identification of Natural Products and World-Approved Drugs Targeting the KEAP1/NRF2 Pathway Endowed with Potential Antioxidant Profile
2023-01-01 Brogi, S.; Guarino, I.; Flori, L.; Sirous, H.; Calderone, V.
Novel Antiviral Agents: Synthesis, Molecular Modelling Studies and Biological Investigation
2023-01-01 Brogi, S.
Structure-Based High-Throughput Virtual Screening and Molecular Dynamics Simulation for the Discovery of Novel SARS-CoV-2 NSP3 Mac1 Domain Inhibitors
2023-01-01 Yazdani, B.; Sirous, H.; Brogi, S.; Calderone, V.